Search results
Oct 16, 2023 · Novavax’s protein-based vaccine is the latest FDA-authorized COVID booster available this fall. Here’s what you should know
Sep 28, 2022 · The Novavax vaccine can be offered to people who have had COVID-19 in the past. But individuals may choose to delay vaccination for 3 months following the infection. Should pregnant and breastfeeding women be vaccinated?
The Novavax COVID-19 vaccine, sold under the brand names Nuvaxovid and Covovax, among others, is a subunit COVID-19 vaccine developed by Novavax and the Coalition for Epidemic Preparedness Innovations (CEPI).
Novavax COVID-19 vaccine (NVX-CoV2373) About the candidate. NVX-CoV2373 is a protein-based vaccine targeting SARS-CoV-2, the virus that causes COVID-19. Recombinant technology is used to create vaccine nanoparticles, which are then mixed with Matrix-M™ adjuvant to create the ready-to-use NVX-CoV2373 vaccine 1.
Aug 26, 2022 · “A two-dose series of Novavax protein subunit COVID vaccine is now recommended for unvaccinated” individuals who are 12 or older “for primary vaccination against COVID-19.” But it is important to note that “Novavax has to be used for both doses in the primary series,” she said. “You can't mix and match with a different product or type.”
Oct 20, 2022 · The Novavax vaccine is the fourth vaccine to be authorized in the United States for the prevention of COVID-19. Yale Medicine experts answer commonly asked questions about the vaccine.
Oct 17, 2023 · The Novavax COVID-19 Vaccine, Adjuvanted, a monovalent vaccine, has been updated to include the spike protein from the SARS-CoV-2 Omicron variant lineage XBB.1.5 (2023-2024 formula).
